[1]
“A Comparative Study Between Single Dose & Multiple Doses of Mitomycin-C in the Management of Transitional Cell Carcinoma of Urinary Bladder”, Bang J Urology, vol. 20, no. 2, pp. 74–77, Oct. 2020, doi: 10.3329/bju.v20i2.49658.